Joint disease affects over 600 million people worldwide.

RheoCarti addresses this challenge with a next-generation joint implant that replicates the mechanics of natural cartilage—delivering ultra-low friction, intrinsic damping, and smoother, more natural movement.


  • Hip resurfacing implant
  • Reverse total shoulder replacement implant
  • Artificial intervertebral disc
  • Total hip replacement implant
  • Total knee replacement implant


RheoCarti, real movement for active patients.

For human patients

RheoCarti is an ETH Zurich originated orthopedics venture in formation. The concept is being developed by an ETH researcher and professor with expertise in joint biomechanics and implant materials and design. RheoCarti aims to translate advanced cartilage-mimicking materials into next-generation hip resurfacing solutions for both veterinary and human applications.


Check our latest news

News

Feed

10/28/2025, 04:52 PM

Third prize at Shenzhen competition

Congrats! Medrich won third prize at the 9th China (Shenzhen) Innovation & Entrepreneurship International Competition (Zurich Switzerland Division).   More


07/09/2025, 06:28 PM

Presentation at the ESB conference

An abstract entitled “Pre-clinical Assessment of a Low-Wear, Durable Metal–Hydrogel Hybrid Implant for Hip Arthroplasty,” authored by Xiaoyu Du, Isabelle Wüthrich, Tara Hayman, and Stephen J. Ferguson, was...   More


<< Newer



Acknowledgement








Disclaimer
All information provided on this website is for general informational purposes only and is non-binding. No liability is assumed for any errors or omissions, nor for any decisions made based on the content of this website. Product descriptions and technical details are subject to change and do not constitute a legally binding offer. If you have questions regarding product features, technical specifications, or availability, please contact us directly for the most current information.